Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03964831 · ClinicalTrials.gov registry record · NA
Study Comparing the P200TxE and P200DTx
A NA study, sponsored by Optos.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03964831: Completed NA study, sponsored by Optos.
NCT03964831 is a NA study that has completed, run by Optos. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03964831, a NA study, has completed, sponsored by Optos.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The study evaluates image quality between two devices.
Primary Outcome
Results from a qualitative assessment of the clinical utility and image quality of the images from both devices will be assessed from a clinician questionnaire and three independent masked and qualified graders using a four point scale (0-3).
Interventions
- DEVICE P200TxE
- DEVICE P200DTx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-06-18 |
| Est. Completion | 2020-01-14 |
| Phase | NA |
What the finished NCT03964831 record still lists
NCT03964831 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which P200TxE is the first listed.
NCT03964831 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03964831 about?
NCT03964831 is a clinical study titled "Study Comparing the P200TxE and P200DTx". The study evaluates image quality between two devices.
What is the current status of trial NCT03964831?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-06-18. Estimated completion is 2020-01-14.
What interventions are being tested in trial NCT03964831?
The interventions under investigation include: P200TxE (DEVICE), P200DTx (DEVICE).
Who is sponsoring clinical trial NCT03964831?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03964831's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI